Dynogen Pharmaceuticals, Inc.
Records under this name other than patents Dynogen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Dynogen Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,846,823 | Method of treating lower urinary tract disorders Formerly held Lapsed on the fee record Ended Jan 25, 2013 · USPTO record | Lapsed on the fee record | Ended Jan 25, 2013 | USPTO record |
| US 7,470,690 | 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder Formerly held Lapsed on the fee record Ended Dec 30, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 30, 2012 | USPTO record |
| US 7,459,430 | Methods of using ziconotide to treat overactive bladder Formerly held Lapsed on the fee record Ended Dec 2, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 2, 2012 | USPTO record |
| US 7,223,754 | Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders Formerly held Lapsed on the fee record Ended May 29, 2011 · USPTO record | Lapsed on the fee record | Ended May 29, 2011 | USPTO record |
| US 7,220,748 | Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidine for treating of urinary incontinence Formerly held Lapsed on the fee record Ended May 22, 2011 · USPTO record | Lapsed on the fee record | Ended May 22, 2011 | USPTO record |
| US 7,125,848 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators Formerly held Lapsed on the fee record Ended Oct 24, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2010 | USPTO record |
| US 7,115,606 | Method of treating lower urinary tract disorders Formerly held Lapsed on the fee record Ended Oct 3, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2010 | USPTO record |
| US 7,094,786 | Method of treating nausea, vomiting, retching or any combination thereof Formerly held Lapsed on the fee record Ended Aug 22, 2010 · USPTO record | Lapsed on the fee record | Ended Aug 22, 2010 | USPTO record |
| US 7,084,116 | Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators Formerly held Lapsed on the fee record Ended Aug 1, 2010 · USPTO record | Lapsed on the fee record | Ended Aug 1, 2010 | USPTO record |
| US 7,041,704 | Methods of treating gastrointestinal tract disorders using sodium channel modulators Formerly held Lapsed on the fee record Ended May 9, 2010 · USPTO record | Lapsed on the fee record | Ended May 9, 2010 | USPTO record |